Abstract
To the Editor .— We read with interest the January 2005 Pediatrics article by Marlier et al,1 who evaluated the therapeutic value of pleasant odor in the treatment of neonatal apneas unresponsive to caffeine and doxapram. In the Marlier et al study, “cessation in breathing movements >20 seconds” was used to define central apnea. Recent evidence suggests that obstruction of the airway is frequently present in these so-called central apneas.2 Idiong et al3 analyzed >4000 apneas in preterm neonates …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
